In summary, an association of pluripotency factor expression with clinicopathological parameters of gastric cancer patients and the effect of Nanog and KLF4 expression on the spheroid forming capacity and response to cisplatin and TRAIL treatments of gastric cancer cells are described in this study. Here, NANOG is linked to gastric cancer.